New Application: Polylactic Acid (PLA) Used in Pipettes, Reduces Carbon Footprint by 113%!

Recently, the German company elm-plastic introduced the "Bio-Pipette" at the CPHI Frankfurt international pharmaceutical ingredients exhibition.

This is an oral pipette made from bioplastics, suitable for the medical and pharmaceutical fields. The pipette is now officially on the market and was jointly developed by elm-plastic, composite materials producer Biovox, and its distributor Ultrapolymers.

The selected materials are from Biovox's MedEco series, including Polylactic Acid (PLA) or 95% bio-based polyethylene, both certified for medical use. These materials possess various excellent properties, comply with ISO 10993 standards, and can be sterilized using methods such as ethylene oxide (EO) sterilization, radiation sterilization, and SCC sterilization.

The MedEco PLA material developed by Biovox is particularly suitable for injection molding to produce dimensionally stable parts with a good feel in hand. Its hardness and strength enable the production of thin-walled parts, thereby saving material; furthermore, compared to traditional plastics, this material requires lower processing temperatures, significantly reducing energy consumption.

Compared to traditional polyolefin pipettes, the bioplastic pipettes developed by elm-plastic can reduce CO2 emissions by 113% across the entire "cradle-to-gate" lifecycle, providing support for the pharmaceutical industry in achieving sustainable development goals.